Splanchnic vasoconstriction by angiotensin II is arterial pressure dependent. 2002

M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
Dept. of Surgical and Perioperative Science, Anaesthesiology and Intensive Care, Umeå University Hospital, Umeå, Sweden. michael.broome.us@vll.se

BACKGROUND Our hypothesis was that splanchnic vasoconstriction by exogenous angiotensin II (Ang II) is significantly potentiated by local mechanisms increasing vasomotor tone and that splanchnic tissue oxygenation during administration of Ang II is perfusion pressure dependent. The aim was to study local splanchnic circulatory effects and tissue oxygenation during intravenous infusion of Ang II at different levels of regional arterial driving pressure in a whole-body large animal model. METHODS Ang II was infused in incremental doses (0-200 microg x h-1) in anaesthetised instrumented pigs (n=8). Mean superior mesenteric arterial pressure (PSMA) was adjusted by a local variable perivascular occluder. Perivascular ultrasound and laser-Doppler flowmetry were used for measurements of mesenteric venous blood flow and superficial intestinal blood flow, respectively. Intestinal oxygenation was evaluated by oxygen tissue tension (PtiO2) and lactate fluxes. RESULTS Ang II produced prominent and dose-dependent increases in mesenteric vascular resistance (RSMA) when the intestine was exposed to systemic arterial pressure, but Ang II increased RSMA only minimally when PSMA was artificially kept constant at a lower level (50 mmHg) by the occluder. Although Ang II decreased PtiO2 at a PSMA of 50 mmHg, splanchnic lactate production was not observed. CONCLUSIONS We demonstrate that splanchnic vasoconstriction by exogenous Ang II is dependent on arterial driving pressure, suggesting significant potentiation through autoregulatory increases in vasomotor tone. Intestinal hypoxaemia does not seem to occur during short-term infusion of Ang II in doses that significantly increases systemic arterial pressure.

UI MeSH Term Description Entries
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008642 Mesenteric Veins Veins which return blood from the intestines; the inferior mesenteric vein empties into the splenic vein, the superior mesenteric vein joins the splenic vein to form the portal vein. Mesenteric Vein,Vein, Mesenteric,Veins, Mesenteric
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013152 Splanchnic Circulation The circulation of blood through the BLOOD VESSELS supplying the abdominal VISCERA. Mesenteric Circulation,Circulation, Mesenteric,Circulation, Splanchnic,Circulations, Mesenteric,Circulations, Splanchnic,Mesenteric Circulations,Splanchnic Circulations

Related Publications

M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
January 1993, Journal of hepatology,
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
January 2002, British journal of pharmacology,
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
December 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
February 2022, Journal of the American Heart Association,
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
October 1987, International journal of clinical pharmacology, therapy, and toxicology,
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
June 1994, The American journal of physiology,
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
September 1995, Journal of hypertension,
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
January 1983, Hypertension (Dallas, Tex. : 1979),
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
June 1982, Journal of applied physiology: respiratory, environmental and exercise physiology,
M Broomé, and A Aneman, and S Lehtipalo, and C Arnerlöv, and G Johansson, and O Winsö, and B Biber
January 1995, Clinical and experimental hypertension (New York, N.Y. : 1993),
Copied contents to your clipboard!